Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
What is Femoston? Femoston is a hormone replacement therapy (HRT) preparation. It consists of two types of tablets; one containing the active ingredient estradiol, and the other containing two active ingredients, estradiol and dydrogesterone.
Follow all directions given to you by your doctor carefully. The usual dose is one tablet daily.
Oestradiol only tablets: Lactose, hypromellose, maize starch, colloidal anhydrous silica, magnesium stearate, Opadry Y-l-7000 white: hypromellose, polyethylene glycol 400, titanium dioxide (E171) Oestradiol/dydrogesterone tablets: Lactose, hypromellose, maize starch, colloidal anhydrous silica, magnesium stearate, Opadry II grey 85F27664: polyvinyl alcohol, Macrogol 3350, talc titanium dioxide(E171), iron oxide black (E172)
For the treatment of postmenopausal symptoms, HRT should only be initiated for symptoms that adversely affect quality of life. In all cases, a careful appraisal of the risks and benefits should be undertaken at least annually and HRT should only be continued as long as the benefit outweighs the risk. Evidence regarding the risks associated with HRT in the treatment of premature menopause is limited. Due to the low level of absolute risk in younger women, however, the balance of benefits and risks for these women may be more favourable than in older women.
Common side effects of Femoston include Weight gain, Metrorrhagia, and Edema. While these are the most often observed Femoston side effects, there are can be others also. These have been listed below. Normally, these side effects of Femoston are not long-lasting and go away when the treatment is finished.